BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6766665)

  • 21. Treatment of severe angina pectoris.
    Desai DC; Alexander S
    Med Clin North Am; 1972 May; 56(3):599-609. PubMed ID: 4624627
    [No Abstract]   [Full Text] [Related]  

  • 22. [Exertion 2-dimensional echocardiography in the evaluation of anti-anginal drugs].
    Lai C; Onnis E; Pirisi R; Orani E; Randaccio P
    Cardiologia; 1987 Mar; 32(3):263-70. PubMed ID: 3111688
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of euphyllin, papaverine, nitroglycerin and chloracizin on coronary vessel tone and myocardial oxygen consumption under isolated heart conditions (Langendorf's method)].
    Buianov VV; Kisin IE
    Vestn Akad Med Nauk SSSR; 1963; 18(1):36-41. PubMed ID: 4971963
    [No Abstract]   [Full Text] [Related]  

  • 24. Regional myocardial blood flow, ischemia and antianginal drugs.
    Becker L; Pitt B
    Ann Clin Res; 1971 Dec; 3(6):353-61. PubMed ID: 4400461
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of propranolol on myocardial oxygen balance during exercise in dogs [proceedings].
    Heyndrickx GR; Mabilde C; Pannier JL
    J Physiol; 1979 Oct; 295():41P. PubMed ID: 521953
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemodynamic factors and indirect assessment of myocardial oxygen consumption in the therapy of angina pectoris.
    Asmterdam EA; Mason DT
    Angiology; 1977 Dec; 28(12):844-52. PubMed ID: 23715
    [No Abstract]   [Full Text] [Related]  

  • 27. [Angina pectoris].
    Froment R
    Arch Mal Coeur Vaiss; 1972 Mar; 65(3):291-4. PubMed ID: 4627125
    [No Abstract]   [Full Text] [Related]  

  • 28. The patient with angina. Medical management plus sympathetic, continuous care.
    Kleiger RE; Martin T
    Geriatrics; 1973 Mar; 28(3):74-8. PubMed ID: 4632432
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacologic justification for the use of adrenergic beta receptor blockaders in angina].
    Boissier JR; Giudicelli JF
    Therapie; 1970; 25(2):363-92. PubMed ID: 4403158
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of nitroglycerin and dipyridamole on epicardial and endocardial oxygen tension--further evidence for redistribution of myocardial blood flow.
    Winbury MM; Howe BB; Weiss JR
    J Pharmacol Exp Ther; 1971 Jan; 176(1):184-99. PubMed ID: 4998808
    [No Abstract]   [Full Text] [Related]  

  • 31. [Qualification of patients with angina pectoris for beta-adrenolytic drug treatment].
    Lukasik S; Wrabec K; Nowosad H
    Kardiol Pol; 1974; 17(6):563-8. PubMed ID: 4155457
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anti-anginal action, by opposite mechanisms, of nitroglycerin and propranolol].
    Giani P; Folli G; Bruno L; Binaghi G; Rizzato GF; Bandera L
    Cuore Circ; 1969 Oct; 53(5):213-32. PubMed ID: 4984065
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of nitroglycerin on regional myocardial blood flow abnormality induced by atrial pacing; a clinical study in myocardial infarction (author's transl)].
    Naka M; Tsuji K; Arai H
    Kokyu To Junkan; 1982 Feb; 30(2):173-81. PubMed ID: 6805060
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pathogenetic mechanisms of angina pectoris].
    Maseri A; Mimmo R; Chierchia S; Marzilli M; Pesola A; L'Abbate A; Parodi O
    Minerva Med; 1975 May; 66(39):1859-76. PubMed ID: 1128825
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of the adrenergic nervous system in the treatment of angina pectoris.
    Epstein SE; Braunwald E
    Med Clin North Am; 1968 Sep; 52(5):1031-9. PubMed ID: 4970537
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proceedings: The effect of nitrates on the systemic circulation and the myocardial oxygen consumption].
    Tauchert M; Behrenbeck DW; Niehues B; Hilger HH
    Z Kardiol; 1975; Suppl 2():84. PubMed ID: 812281
    [No Abstract]   [Full Text] [Related]  

  • 38. On the mode of action of antianginal drugs.
    Szekeres L
    Basic Res Cardiol; 1978; 73(2):133-46. PubMed ID: 26329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adrenergic and anti-adrenergic mechanisms of substances with anti-anginal effects].
    Palm D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):159-67. PubMed ID: 4389904
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular pharmacology of propranolol in man.
    Wolfson S; Gorlin R
    Circulation; 1969 Oct; 40(4):501-11. PubMed ID: 5823547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.